![Michelle Yanez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Yanez
Direktor/Vorstandsmitglied bei
HEDGEPATH PHARMACEUTICALS INC
Vermögen: 75 287 $ am 31.05.2026
Profil
Ms. Michelle Yanez is an Independent Director at Inhibitor Therapeutics, Inc., a Member at Institute of Management Accountants, Inc. and a Member at Sec Professionals Group.
She is on the Board of Directors at Inhibitor Therapeutics, Inc. Ms. Yanez was previously employed as a Chief Financial Officer, Secretary & Treasurer by MIRA Pharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Telomir Pharmaceuticals, Inc., and a Director-Financial Reporting by BioDelivery Sciences International, Inc. She received her undergraduate degree from the University of South Florida and an MBA from Rutgers Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2025 | 896’271 ( 0.52% ) | 75 287 $ | 31.05.2026 |
Aktive Positionen von Michelle Yanez
| Unternehmen | Position | Beginn |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 13.10.2023 |
Institute of Management Accountants, Inc.
 Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a association of accountants and financial professionals | Corporate Officer/Principal | - |
Sec Professionals Group | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michelle Yanez
| Unternehmen | Position | Ende |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 16.05.2025 |
| TELOMIR PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 15.05.2025 |
| HEDGEPATH PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 14.05.2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Corporate Officer/Principal | 01.04.2022 |
Ausbildung von Michelle Yanez
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Management Accountants, Inc.
Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a association of accountants and financial professionals | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sec Professionals Group | Commercial Services |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
